Skip to Content

Fresenius SE & Co KGaA FRE

Morningstar Rating
€29.10 +0.47 (1.64%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

FRE is trading at a 423% premium.
Price
€28.63
Fair Value
€86.00
Uncertainty
High
1-Star Price
€94.90
5-Star Price
€55.00
Economic Moat
Sykjxd
Capital Allocation
Rzktpfdrj

Bulls Say, Bears Say

Bulls

Underlying demographic trends and international expansion opportunities should keep Fresenius’ dialysis services and related medical product growth in positive territory as the pandemic recedes.

Bears

Until the US achieves universal affordable coverage, policy risks around reimbursement for dialysis services may continue to add risk to the story.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FRE is a good fit for your portfolio.

News

Trading Information

Previous Close Price
€28.63
Day Range
€28.6629.61
52-Week Range
€23.9331.22
Bid/Ask
€29.01 / €0.00
Market Cap
€16.39 Bil
Volume/Avg
1.2 Mil / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
6.31
Price/Sales
0.59
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Large Value
Total Number of Employees
190,863

Competitors

Valuation

Metric
FRE
ICUI
DVA
Price/Earnings (Normalized)
6.3119.7315.03
Price/Book Value
0.831.3913.07
Price/Sales
0.591.261.04
Price/Cash Flow
13.7410.466.42
Price/Earnings
FRE
ICUI
DVA

Financial Strength

Metric
FRE
ICUI
DVA
Quick Ratio
0.600.921.30
Current Ratio
1.352.611.43
Interest Coverage
2.85−0.054.36
Quick Ratio
FRE
ICUI
DVA

Profitability

Metric
FRE
ICUI
DVA
Return on Assets (Normalized)
2.43%3.32%6.99%
Return on Equity (Normalized)
7.80%6.94%118.17%
Return on Invested Capital (Normalized)
4.23%5.84%10.75%
Return on Assets
FRE
ICUI
DVA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA Healthcare Inc
HCA
GdsylpbfNtgptc$85.5 Bil
Fresenius SE & Co KGaA
FSNUF
Jdwz$17.4 Bil
Fresenius SE & Co KGaA ADR
FSNUY
Hvgt$17.4 Bil
Tenet Healthcare Corp
THC
MdqtmllPvhvc$13.3 Bil
Universal Health Services Inc Class B
UHS
Blzfbt$12.4 Bil
DaVita Inc
DVA
MlxgjzssMgqyxj$12.1 Bil
Bangkok Dusit Medical Services PCL ADR
BDUUY
Htyr$11.5 Bil
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt
BDUUF
Qhcj$11.5 Bil
Fresenius Medical Care AG ADR
FMS
YqxrnBpwgp$11.4 Bil
AMN Healthcare Services Inc
AMN
QtbyjdzpHsgvrn$1.9 Bil

Sponsor Center